NCT01580618 2026-04-14
Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy
Kaiser Permanente
Phase 2/3 Terminated
Clinical Trials
61 trialsNCT05131776 2026-03-23
EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.
Chinese University of Hong Kong
Phase 2/3 Terminated
NCT03870750 2026-01-12
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
Fred Hutchinson Cancer Center
Phase 2/3 Terminated
NCT05171166 2025-12-18
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
Peking University
Phase 2/3 Terminated
NCT05454358 2025-12-15
Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP
Fudan University
Phase 2/3 Terminated
NCT04159155 2025-08-12
CAN-STAMP
University Health Network, Toronto
Phase 2/3 Terminated
NCT06281106 2025-04-02
TYPP
Centre Hospitalier Universitaire Vaudois
Phase 2/3 Terminated
NCT00448240 2025-03-18
Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
Henry Ford Health System
Phase 2/3 Terminated
NCT04901988 2025-02-27
DETECTION
The Christie NHS Foundation Trust
Phase 2/3 Terminated
NCT02551458 2024-03-07
Esostrate
Centre Hospitalier Universitaire Dijon
Phase 2/3 Terminated
NCT00630565 2024-01-29
Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
Masonic Cancer Center, University of Minnesota
Phase 2/3 Terminated
NCT00227617 2023-05-22
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
University of California, San Francisco
Phase 2/3 Terminated
NCT01907009 2023-04-19
MEL-CAP
Barts & The London NHS Trust
Phase 2/3 Terminated
NCT02288377 2023-01-18
REMINET
Federation Francophone de Cancerologie Digestive
Phase 2/3 Terminated
NCT00096460 2023-01-05
BMT CTN 0202
Medical College of Wisconsin
Phase 2/3 Terminated
NCT03870152 2022-10-31
EARL
University College, London
Phase 2/3 Terminated
NCT00247975 2022-08-16
Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
Ottawa Heart Institute Research Corporation
Phase 2/3 Terminated
NCT02614703 2021-08-27
"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance
DHR Health Institute for Research and Development
Phase 2/3 Terminated
NCT02354144 2021-06-15
LIMIT-HPV
McGill University
Phase 2/3 Terminated
NCT01437514 2021-06-07
Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
West China Hospital
Phase 2/3 Terminated
NCT03158610 2021-05-03
Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer
Ruijin Hospital
Phase 2/3 Terminated
NCT00448266 2021-01-22
Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD
The Netherlands Cancer Institute
Phase 2/3 Terminated
NCT03716050 2020-05-21
The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems
Wake Forest University Health Sciences
Phase 2/3 Terminated
NCT02256124 2020-04-14
NF1-EXCEL
Erasmus Medical Center
Phase 2/3 Terminated
NCT01902823 2019-12-13
Effect of Cancer Nurse Navigators on Patient Outcomes
University of Wisconsin, Madison
Phase 2/3 Terminated
NCT00539500 2019-07-26
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
M.D. Anderson Cancer Center
Phase 2/3 Terminated
NCT01193530 2019-03-26
The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2/3 Terminated
NCT02356640 2019-01-30
EUS-guided CGN for Inoperable Cancer
Chinese University of Hong Kong
Phase 2/3 Terminated
NCT02145598 2019-01-16
GERMAIN
University of Jena
Phase 2/3 Terminated
NCT02220088 2019-01-11
The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial
Sun Yat-sen University
Phase 2/3 Terminated
NCT01446874 2018-11-08
POPP
Washington University School of Medicine
Phase 2/3 Terminated
NCT00038805 2018-10-31
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center
Phase 2/3 Terminated
NCT01588951 2018-08-14
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2/3 Terminated
NCT00169104 2018-07-20
Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function
Dartmouth-Hitchcock Medical Center
Phase 2/3 Terminated
NCT02163187 2018-02-05
Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation
Memorial Sloan Kettering Cancer Center
Phase 2/3 Terminated
NCT01683864 2018-01-30
HIPECStomach
University Hospital Tuebingen
Phase 2/3 Terminated
NCT02326285 2018-01-23
NeoIntercal
AIO-Studien-gGmbH
Phase 2/3 Terminated
NCT01803711 2017-12-27
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
UConn Health
Phase 2/3 Terminated
NCT00176839 2017-12-05
Stem Cell Transplantation for Hematological Malignancies
Masonic Cancer Center, University of Minnesota
Phase 2/3 Terminated
NCT00684216 2017-09-14
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
The Netherlands Cancer Institute
Phase 2/3 Terminated
NCT00714259 2017-07-24
Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
University of Alabama at Birmingham
Phase 2/3 Terminated
NCT01931592 2017-05-08
CLEAR
University of Cologne
Phase 2/3 Terminated
NCT01704690 2017-04-07
Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer
Peking University
Phase 2/3 Terminated
NCT01319669 2017-03-03
Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
Chinese Society of Lung Cancer
Phase 2/3 Terminated
NCT01708798 2017-01-05
Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
University of British Columbia
Phase 2/3 Terminated
NCT00984828 2016-09-08
Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Terminated
NCT01981707 2016-04-28
PRECHOL
University Hospital, Grenoble
Phase 2/3 Terminated
NCT00381836 2015-12-04
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer
University of Aarhus
Phase 2/3 Terminated
NCT01809171 2015-10-21
Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Terminated
NCT00934739 2015-02-25
A Study of High-Risk Oral Cavity Cancer
National Health Research Institutes, Taiwan
Phase 2/3 Terminated